Does Lacosamide Affect Blood Pressure?
Lacosamide, an antiepileptic drug sold as Vimpat, lists hypotension (low blood pressure) as a possible side effect, though it's uncommon. Clinical trials and post-marketing data report it in less than 1% of patients, often linked to rapid IV infusion or high doses. Hypertension (high blood pressure) appears even less frequently.[1][2]
How Common Is It and Who Gets It?
Hypotension occurs in about 0.5-1% of patients on oral lacosamide, rising slightly with IV use due to infusion-related drops. It's more likely in those with heart conditions, on blood pressure meds, or during dose increases. No strong evidence ties it to chronic hypertension.[2][3]
What Do Patients Report?
Real-world reports on forums and FDA adverse event databases note occasional dizziness or lightheadedness from blood pressure dips, especially early in treatment. Most resolve without stopping the drug, but some need dose adjustments.[3]
Compared to Other Epilepsy Drugs?
Unlike carbamazepine or phenytoin, which rarely impact blood pressure, lacosamide's cardiac effects (like PR interval prolongation) indirectly contribute to hypotension risk. Lamotrigine and levetiracetam show minimal vascular effects.[2][4]
What Should You Watch For?
Monitor for symptoms like fainting, fatigue, or rapid heartbeat during the first weeks or IV dosing. The prescribing label advises caution in heart failure patients and slower IV rates (no faster than 60 mg/min) to minimize drops. Consult a doctor before combining with antihypertensives.[1][2]
Any Long-Term Risks?
No data shows sustained blood pressure changes with prolonged use. Trials up to 7 years report no cumulative vascular effects beyond initial risks.[2]
[1]: Vimpat Prescribing Information (FDA)
[2]: Drugs.com - Lacosamide Side Effects
[3]: FDA FAERS Database Summary
[4]: Epilepsy Foundation Drug Comparison